ANAVEX Advances Drug Candidates For Treatment Of Epilepsy Part 2

The pre-clinical den tested the anti-amnesic belongings of ANAVEX 2-73 and ANAVEX 19-144 next to mice, which be later submit to short- and long-term reminiscence assessment, headlong alternation and biddable skirting respectively. Testing be conduct contained with pharmacological and pathological mouse stunning of amnesia. When the epilepsy remedy hopeful were administered to the mice, the amalgamated dose reversed the erudition deficit induce by the drugs scopolamine and dizocilpine and by the direction of amyloid beta peptide. The effects of ANAVEX 2-73 were related to deeds at muscarinic and sigma-1 receptor site because they were treacherous by pre-injection of the sigma-1 receptor antagonist BD 1047.

The neuroprotective properties of ANAVEX 2-73 and ANAVEX 19-144 were studied in a non-transgenic mouse model of Alzheimer's virus. Central immunisation of amyloid beta peptide in mouse organizer be pernickety to reimburse bygone its sell-by date histological and biochemical change, oxidative weight and learning deficits in seven days. ANAVEX 2-73 or ANAVEX 19-144 administered once, any vocally or by injection, prevented the veneer of amyloid beta peptide-induced learning or memory deficits. It also prevented oxidative stress, which damages and destroy cell, and sassiness cell demise in moody spread of the brainpower that standardize learning, mood and memory. In postscript, the neuroprotective properties of ANAVEX 19-144 personal be demonstrated, in a transient focal mind ischemia mouse model, to decrease the infarct area after ischemia by 28%.

3. Jorge Cortes et al., Efficacy of Nilotinib (AMN107) in Patients with newly diagnosed, once crude Philadelphia Chromosome (Ph)-Positive Chronic Myelogenous Leukemia in reckless Chronic Phase (CML-CP). Oral Presentation. American Society of Hematology Annual Meeting, 2007. Abstract #29.

online pharmacy cialis now